secwatch.observer — SEC 8-K summary
======================================

Issuer:     Baudax Bio, Inc. (—)
CIK:        0001780097
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001193125-23-088239
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 1.02, 2.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Baudax Bio transfers ANJESO assets to Alkermes, amends credit, issues warrants
------------------------------------------------------------------------------

- Transferred ANJESO patents, trademarks, equipment, data to Alkermes; NDA withdrawal and potential later transfer; all related agreements terminated with no further payments.
- Amended credit agreement: lenders consented to asset transfer, released liens on transferred assets, reduced minimum liquidity covenant to $2.5M.
- Issued 785,026 warrants to MAM Eagle Lender at $1.8951/share, 10-year term, with registration rights.
- Will pay $567,500 amendment fee in 12 monthly installments to lenders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1780097/000119312523088239/0001193125-23-088239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1780097/000119312523088239/d454236d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-088239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer